Published: 19-12-2022
Review
Chylothorax associated with sarcoidosis: a review of the literature
Abstract 521 | PDF Downloads 437Page e2022039
Original Articles: Clinical Research
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF
Abstract 664 | PDF Downloads 554Page e2022035
Infliximab decreases inflammatory activity but has no effect on small fiber neuropathy related symptoms in Dutch patients with sarcoidosis
Abstract 561 | PDF Downloads 218Page e2022033
Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
Abstract 947 | PDF Downloads 736Page e2022038
Role of computed tomography findings, complete blood count parameters and systemic inflammatory markers for predicting the severity in interstitial lung diseases
Abstract 693 | PDF Downloads 442Page e2022042
Original Articles: Laboratory Research
Metagenomic sequencing of the bronchoalveolar lavage extracellular virome and cellular transcriptome of sarcoidosis patients does not detect rubella virus
Abstract 573 | PDF Downloads 495Page e2022040
Case Reports
A case of hepatic and bone marrow sarcoidosis with progressive renal failure: diagnostic and therapeutic challenges
Abstract 465 | PDF Downloads 419Page e2022041
Letter to Editor
Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: A therapeutic controversy
Abstract 431 | PDF Downloads 365Page e2022036
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis
Abstract 368 | PDF Downloads 341Page e2022037